查詢結果分析
來源資料
相關文獻
- Home Mechanical Ventilation: Investigation of 34 Cases in Taiwan
- Home Mechanical Ventilation in Central Taiwan: Experiences at China Medical College Hospital
- 慢性呼吸衰竭之急性加劇
- Rigid Spine Syndrome with Chronic Respiratory Failure
- 建立呼吸照護中心呼吸器脫離之預測指標
- 臺北榮民總醫院胸腔部與呼吸治療科慢性呼吸衰竭病患長期呼吸照顧實施計畫
- 非侵襲性呼吸器於慢性呼吸衰竭之應用
- Effects of Domiciliary Nocturnal Ventilatory Support in Patients with Chronic Respiratory Failure
- 兒童期急性與慢性呼吸衰竭的處置
- 慢性呼吸衰竭患者脫離呼吸器的中醫會診病例報告
頁籤選單縮合
題 名 | Home Mechanical Ventilation: Investigation of 34 Cases in Taiwan=臺灣地區居家呼吸器治療調查 |
---|---|
作 者 | 林孟志; 黃崇旂; 藍瑞熙; 蔡熒煌; | 書刊名 | 長庚醫學 |
卷 期 | 19:1 1996.03[民85.03] |
頁 次 | 頁42-49 |
分類號 | 415.415 |
關鍵詞 | 居家呼吸器治療; 長期呼吸器治療; 慢性呼吸衰竭; Home mechanical ventilation; HMV; Long-term mechanical ventilation; Chronic respiratory failure; |
語 文 | 英文(English) |
中文摘要 | 為了瞭解臺灣要目前在家使用呼吸器治療的病人的接受程度及其特性,我們在民國81年8月份經由臺灣地區提供居家呼吸治療服務及儀器設備的公司,作了一全面性的調查。共有34個病例進入我們的研究,其中包括了18位男性和16位女性。依其造成呼吸衰竭之原發疾病,我們把病人共分成四個人同類型的疾病群以利分析,分別是符(1)原發性肺疾病,包括了慢性阻塞性肺疾病和瀰漫性支氣管擴張症者,共7例。(2)神經肌肉疾病患者,包括了各種因神經退化性或肌肉性疾病造成呼吸衰竭者,共有14例。(3)脊髓疾患患者,包括了由於脊髓損傷或腫瘤致呼吸衰竭之病患,共7例。因腦血管病變,意識不清致呼吸器依賴患者,共6例。所有病患當中有15人在當時已使用居家陽壓呼吸器超過一年,有26人(76.5%)是必需完全依賴而無法短脫離。同時第四類病患的花費亦比其他三組病人來得高。使用居家呼吸器後再次住院的原因有肺炎(3例),氣切傷口感染(1例),氣切息肉形成氣管阻塞(2例),或其他呼吸器脫離問題(2例),氣切傷口感染(1例),氣切息肉形成氣管阻塞(2例),或其他呼吸器脫離問題(2例)。我們在四個月及一年後對相同病患儘了追?調查,發覺在一年後的存活率,第五組肺部疾患是14.3%;第二組神經肌肉及第四組中風患者都是50%,而全部脊髓病變患者在研究結束仍存活著。大部份的患者及家屬均對目前居家呼吸器使用感到滿意。從我們的調查,我們認為居家呼吸器使用對於在醫院長期使用呼吸器的穩定患者是一種可被接受的變通方式。因肌肉神經病變及脊髓傷害而致呼吸衰竭的患者是比較合適的對象。大部份患者一年存活辛都不錯,其中以脊髓病患類者預後最佳,任何患者只要活過11個月,就有絕佳的機會再活第二年。 |
英文摘要 | To evaluate the characteristics of and acceptance by persons in Taiwan who currently use positive-pressure mechanical ventilation at home (HMV), a survey was conducted in August 1992 through home care and equipment providers to investigate these patients. The 34 cases enrolled, including 18 males and 16 females, were classified into four groups: (1) lung disease group (LD) (n=7) including chronic obstructive pulmonary disease and bronchiectasis; (2) neuromuscular group (NM) (n=14) including diverse neuromuscular diseases; (3) spinal disease group (SP) (n=7) including spinal cord injuries or tumors and (4) unresponsive stroke group (US) (n=6). The average age of the SP group was much younger than those of the other three groups. The duration of home ventilation was from 1 to 36 months, with a mean duration of 10.6±8.7 months. Fifteen cases had received HMV for more than one year. Twenty six (76.5%) of the patients were completely dependent. All of the US patients had to be ventilated all day long in contrast to 71.4% of LD completely dependent. The cost of the US group was higher than that of the other three groups. Two of the LD, five of NM and one US patient had been re-admitted because of pneumonia, tracheotomy wound infection, granulation formation or weaning problems before the study. A follow-up survey was done four months, then one year later. The survival rate 16.7% for LD group, 50% for NM and US group. Of the SP group, all patients were surviving at the end of this study. Most of the present HMV users were satisfied with their setting. It was concluded that HMV users were satisfied with their setting. It was concluded that HMV is an acceptable alternative was of therapy for long-term ventilation patients in Taiwan. SP and NM patients are better candidates for HMV. The overall one year survival rate is promising, while SP patients had best prognosis. Patients who had already used HMV for more than 11 months, regardless of the disease, have a better chance to live another year. |
本系統中英文摘要資訊取自各篇刊載內容。